Advertisement
Screener

Janux Therapeutics, Inc. (JANX) ROE

Janux Therapeutics, Inc. (JANX) ROE

  • 2026-06-30: ROE -11.06%.
  • 2026-03-31: ROE -12.16%.
  • 2025-12-31: ROE -11.88%.
  • 2025-09-30: ROE -10.43%.

Complete source-backed roe history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-11.06%
2026-03-31-12.16%
2025-12-31-11.88%
2025-09-30-10.43%
2025-06-30-10.67%
2025-03-31-7.68%
2024-12-31-6.75%
2024-09-30-9.23%
2024-06-30-6.70%
2024-03-31-8.48%
2023-12-31-16.93%
2023-09-30-17.94%
2023-06-30-22.62%
2023-03-31-21.56%
2022-12-31-19.66%
2022-09-30-18.22%
2022-06-30-15.85%
2022-03-31-12.30%
2021-12-31-8.92%
2021-09-30-5.55%
2021-06-30-2.96%
2021-03-3145.64%

Annual ROE

DateROE
2025-12-31-11.88%
2024-12-31-6.75%
2023-12-31-16.93%
2022-12-31-19.66%
2021-12-31-8.92%
2020-12-3146.35%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Savara Inc (SVRA)United States$1.044B-9.10
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93